360570-01-0Relevant articles and documents
Discovery of potent and selective phenylalanine derived CCR3 receptor antagonists. Part 2
Dhanak, Dashyant,Christmann, Lisa T,Darcy, Michael G,Keenan, Richard M,Knight, Steven D,Lee, Judithann,Ridgers, Lance H,Sarau, Henry M,Shah, Dinubhai H,White, John R,Zhang, Lily
, p. 1445 - 1450 (2007/10/03)
Highly potent CCR3 antagonists have been developed from a previously reported series of phenylalanine ester-based leads. Solution-phase, parallel synthesis optimization was utilized to identify highly potent, functional CCR3 antagonists.